✦ LIBER ✦

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

✍ Scribed by Strober, B.; Buonanno, M.; Clark, J.D.; Kawabata, T.; Tan, H.; Wolk, R.; Valdez, H.; Langley, R.G.; Harness, J.; Menter, A.; Papp, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase 2a efficacy and safet

✍ Ports, W.C.; Khan, S.; Lan, S.; Lamba, M.; Bolduc, C.; Bissonnette, R.; Papp, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

Efficacy and safety of topical janus kin

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The effectiveness of tofacitinib, a nove

✍ Paweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, Andrzej Pilc 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 323 KB

Efficacy and safety of tofacitinib, an o

✍ K.A. Papp; A. Menter; B. Strober; R.G. Langley; M. Buonanno; R. Wolk; P. Gupta; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Cost-effectiveness of biologic treatment

✍ Andrew A. Nelson; Daniel J. Pearce; Alan B. Fleischer Jr.; Rajesh Balkrishnan; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB

The effects of water and non-nutritive s

✍ Peters, John C.; Wyatt, Holly R.; Foster, Gary D.; Pan, Zhaoxing; Wojtanowski, A 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB